Jae Sook Ahn

The Clinical Outcome of FLAG Chemotherapy without Idarubicin in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Se Ryeon Lee, Deok Hwan Yang, Jae Sook Ahn et al. · Journal of Korean Medical Science · 2009 · 27 citations · Full text

Medicine, Pharmacology, Immuno-oncology Pharmacotherapy +14

HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia

Jong-Ho Park, Young Min Woo, Emilia Moonkyung Youm et al. · Leukemia · 2018 · 22 citations · Full text

Medicine, Molecular Biology, Oncology +14

Phase II Study of Paclitaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy in Patients with Advanced Gastric Cancer

Junyl Hwang, Sang‐Hee Cho, Hyun Jeong Shim et al. · Journal of Korean Medical Science · 2008 · 13 citations · Full text

Medicine, Oncology, Pharmacology +13

Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD

Dong Won Baek, Hee Jeong Cho, Ju‐Hyung Kim et al. · Cell Transplantation · 2022 · 13 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +9

Dermatomyositis Associated with Cancer of Unknown Primary Site

Sung Hoon Chung, Jun‐Eul Hwang, Sang H. Kim et al. · Journal of Korean Medical Science · 2007 · 12 citations · Full text

Medicine, Dermatology, Oncology +16